<DOC>
	<DOCNO>NCT02381782</DOCNO>
	<brief_summary>Over last year , considerable interest development screening tool assess capability elderly cancer patient tolerate anti-cancer treatment . Therefore , NCCN Guidelines Senior Adult Oncology recommend assessment co-morbid condition likely interfere cancer treatment tolerability . As presbyacusis common old population , elderly cancer patient high risk social isolation reduce quality life . Therefore , project investigator aim validatie uHear™ quick reliable screen tool screen presbyacusisf routine clinical oncology practice .</brief_summary>
	<brief_title>Validation uHear™ Screening Tool Detect Hearing Impairment Elderly Cancer Patients Within Comprehensive Geriatric Assessment</brief_title>
	<detailed_description />
	<mesh_term>Hearing Loss</mesh_term>
	<mesh_term>Deafness</mesh_term>
	<criteria>Patients reach age 70 enrolment Histologically confirm diagnosis solid cancer hematologic malignancy . All stage cancer eligible Patients fluent Dutch French Patients must receive primary oncology care participate hospital Patients cognitively capable perform audiology assessment Patients sign informed consent Patients match inclusion criterion Patients visit oncology clinic second opinion wish treat clinic Patients present clinically diagnose Ménière 's disease , retrocochlear hearing loss , autoimmune inner ear disease , fluctuate hearing loss history sudden sensory neural hearing loss Patients already hear aid previously diagnose hearing loss</criteria>
	<gender>All</gender>
	<minimum_age>70 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2015</verification_date>
</DOC>